UA100129C2 - Use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate for the treatment or prevention of atherosclerosis - Google Patents
Use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate for the treatment or prevention of atherosclerosisInfo
- Publication number
- UA100129C2 UA100129C2 UAA201006835A UAA201006835A UA100129C2 UA 100129 C2 UA100129 C2 UA 100129C2 UA A201006835 A UAA201006835 A UA A201006835A UA A201006835 A UAA201006835 A UA A201006835A UA 100129 C2 UA100129 C2 UA 100129C2
- Authority
- UA
- Ukraine
- Prior art keywords
- trimethylhydrazinium
- atherosclerosis
- prevention
- treatment
- dihydrogen phosphate
- Prior art date
Links
- 201000001320 Atherosclerosis Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- DSMFFOSDNKPHJP-TYYBGVCCSA-N (e)-but-2-enedioic acid;propanoic acid Chemical compound CCC(O)=O.OC(=O)\C=C\C(O)=O DSMFFOSDNKPHJP-TYYBGVCCSA-N 0.000 title 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 title 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Abstract
Novel medical use of 3-(2,2,2-trimethylhydrazinium) propionate salts for the manufacture of a medicament for prevention and therapy of atherosclerosis.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07122272 | 2007-12-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA100129C2 true UA100129C2 (en) | 2012-11-26 |
Family
ID=38922681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201006835A UA100129C2 (en) | 2007-12-04 | 2008-12-03 | Use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate for the treatment or prevention of atherosclerosis |
Country Status (2)
| Country | Link |
|---|---|
| ES (1) | ES2370134T3 (en) |
| UA (1) | UA100129C2 (en) |
-
2008
- 2008-12-03 ES ES08857026T patent/ES2370134T3/en active Active
- 2008-12-03 UA UAA201006835A patent/UA100129C2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2370134T3 (en) | 2011-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009011444A (en) | Titration of tapentadol. | |
| EA019970B8 (en) | Imidazolidinedione derivatives | |
| MX361732B (en) | Compositions and methods for modulation of smn2 splicing in a subject. | |
| IL160420A0 (en) | Treating or preventing diabetes with cannabidiol | |
| WO2007146426A3 (en) | Nanoshells for drug delivery | |
| WO2010014690A3 (en) | Medical devices for therapeutic agent delivery | |
| MX2010002498A (en) | Methods of treating or preventing respiratory tract infection comprising administering cholecalciferol. | |
| NZ599928A (en) | Use of pentosan polysulfate for treatment or prophylaxis of asthma | |
| MX2009011712A (en) | Enhanced formulations of lamotrigine. | |
| NZ598489A (en) | Combination therapy for treating proliferative diseases | |
| CY1114760T1 (en) | Atherosclerosis Therapeutic Treatment | |
| TN2010000250A1 (en) | Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate | |
| MX2009006869A (en) | Method and system for enhancing self-treatment of onychomycosis. | |
| MY158799A (en) | New medical use of 3-(2,2,2-trimethylhydrazinium) propionate salts | |
| UA100129C2 (en) | Use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate for the treatment or prevention of atherosclerosis | |
| UA49089U (en) | Method for treating acute heart failure | |
| MX2009003253A (en) | Derivatives of 5-thioxylopyranose and use of same for treatment. | |
| UA32892U (en) | Method for treatment of patients suffering from pulmonary tuberculosis | |
| UA32871U (en) | Method for treatment of patients suffering from pulmonary tuberculosis | |
| EP2067473A3 (en) | Medical use of 3-(2,2,2-trimethylhydrazinium) propionate salts | |
| UA29829U (en) | Method for treating non-proliferative diabetic retinopathy | |
| UA27836U (en) | Method for treating community-acquired pneumonia of group 3 in adult patients | |
| UA39741U (en) | Technique for drainage after thyroid surgery | |
| UA52206U (en) | Method for treating cognitive impairments |